Monthly ianalumab reduced systemic disease activity in Sjögren’s disease, but symptom improvements remained limited.
Researchers evaluated retatrutide in the TRIUMPH-1-OSA and TRIUMPH-2-OSA trials, which enrolled adults with ...
Taking multiple medications can increase adverse interactions and side effects, making regular medication reviews essential.
Our finding that patients treated with a 5αRI at the time of PCI-treated STEMI experienced fewer severe complications post MI ...
New data show univariate 24-month overall survival rates of 56.2% with proton therapy compared with 69.3% with photon therapy ...
Evidence supporting the efficacy and acceptable safety of upadacitinib has grown since the publication of the 2022 ASAS-EULAR ...
The patient cannot become the least powerful person in the system built to provide their care,” says Amran Kahn, MD.
Findings suggest that preoperative caudal block should be administered in most cases prior to pediatric infraumbilical ...
Asthma- and/or COPD-associated emergency department visits rose 3.2% within two days of exposure to increased fine ...
As patients navigate conflicting messages, physicians can provide an important and credible voice,” says Stephen Parodi, MD.
Need a dose of dark humor? This week’s medical cartoon features a patient whose baseline treatment plan already includes strict UV avoidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results